分次放疗较立体定向放射外科治疗WHO 2级脑膜瘤的肿瘤总体控制与颅内控制获益
本机构队列纳入32例WHO 2级脑膜瘤伴残留或复发肿瘤患者,比较辅助分次放疗与挽救性立体定向放射外科(SRS)的疾病控制结局。中位随访5.5年,分次放疗组5年肿瘤总体控制(GTC)和颅内控制(IC)均显著高于SRS组。单因素分析中BED10升高与更好的GTC显著相关。
要点
- 分次放疗组5年GTC为82%,SRS组为38%(P=0.03)。
- 分次放疗组5年IC为82%,SRS组为11%(P<0.001)。
- 单因素分析中BED10升高与更好的GTC显著相关(P=0.039)。
核心结论
- 在该患者队列中,辅助分次放疗组的GTC和IC显著高于挽救性SRS组,BED10升高与更好的GTC相关,分次放疗可能为2级脑膜瘤提供优于SRS的治疗比。
研究设计与样本
- 本机构数据库回顾性识别32例WHO 2级脑膜瘤伴残留或复发肿瘤患者,2007年至2021年接受SRS或分次放疗,随访至少1年。
- 采用Kaplan-Meier法评估肿瘤总体控制(GTC)和颅内控制(IC),使用以生物有效剂量(BED)为连续变量的单因素Cox比例风险模型评估剂量反应。
主要发现
- 中位随访5.5年,13例(41%)接受SRS治疗复发或进展结节,2例(6%)接受分次放疗治疗复发或进展结节,17例(53%)次全切除后接受辅助分次放疗。
- 5年GTC分次放疗组为82%,SRS组为38%(P=0.03)。
- 5年IC分次放疗组为82%,SRS组为11%(P<0.001)。
- 单因素分析中,BED10升高与更好的GTC显著相关(P=0.039);BED3升高与GTC无显著相关(P=0.82)。
临床怎么用
- 作者认为,对于2级脑膜瘤,分次放疗可能提供比SRS更好的治疗比。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Surgical resection is the mainstay of treatment for WHO grade 2 meningioma. Fractionated radiation therapy (RT) is frequently used after surgery, though many centers utilize stereotactic radiosurgery (SRS) for recurrence or progression. Herein, we report disease control outcomes from an institutional cohort with adjuvant fractionated RT versus salvage SRS. METHODS: We identified 32 patients from an institutional database with WHO grade 2 meningioma and residual/recurrent tumor treated with either SRS or fractionated RT. Patients were treated between 2007 and 2021 and had at least 1 year of follow-up. Kaplan-Meier estimators were used to determine gross tumor control (GTC) and intracranial control (IC). Univariate Cox proportional hazards models using biologically effective dose (BED) as a continuous parameter were used to assess for dose responses. RESULTS: With a median follow-up of 5.5 years, 13 patients (41%) received SRS to a recurrent or progressive nodule, 2 (6%) fractionated RT to a recurrent or progressive nodule, and 17 (53%) adjuvant fractionated RT following subtotal resection. Five-year GTC was higher with fractionated RT versus SRS (82% vs. 38%, P = 0.03). Five-year IC was also better with fractionated RT versus SRS (82% vs. 11%, P < 0.001). On univariate analysis, increasing BED10 was significantly associated with better GTC (P = 0.039); increasing BED3 was not (P = 0.82). CONCLUSIONS: In this patient cohort, GTC and IC were significantly higher in patients treated with adjuvant fractionated RT compared with salvage SRS. Increasing BED10 was associated with better GTC. Fractionated RT may provide a better therapeutic ratio than SRS for grade 2 meningiomas.
引用
- Gravbrot N, Rock CB, Weil CR, et al. Gross Tumor and Intracranial Control Benefits with Fractionated Radiotherapy Compared with Stereotactic Radiosurgery for Patients with WHO Grade 2 Meningioma. World Neurosurg. 2024. PMID: 38777319. doi:10.1016/j.wneu.2024.05.093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。